MUFG Securities Americas’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.2M Buy
21,922
+528
+2% +$535K 1.3% 12
2025
Q4
$23M Sell
21,394
-45
-0.2% -$43K 1.43% 12
2025
Q3
$16.4M Buy
21,439
+4,005
+23% +$2.98M 1.06% 12
2025
Q2
$13.6M Buy
17,434
+3,487
+25% +$2.71M 1.16% 12
2025
Q1
$11.5M Buy
13,947
+2,316
+20% +$1.93M 1.34% 12
2024
Q4
$8.98M Buy
+11,631
New +$9.63M 1.14% 14

Other funds holding LLY

MUFG Securities Americas's LLY Position: Q1 2026 in Review

MUFG Securities Americas increased its Eli Lilly (LLY) stake by 2.5% in Q1 2026, buying an estimated $535K and bringing the position to 21,922 shares worth $20.2M. The position accounts for 1.3% of the portfolio, ranked #12.

MUFG Securities Americas first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $23M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • MUFG Securities Americas held 21,922 shares of Eli Lilly worth $20.2M as of Q1 2026.
  • MUFG Securities Americas bought 528 Eli Lilly shares in Q1 2026, an estimated $535K.
  • Eli Lilly made up 1.3% of MUFG Securities Americas's portfolio in Q1 2026, its #12 holding.
  • MUFG Securities Americas first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • MUFG Securities Americas's Eli Lilly position peaked at $23M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.